A Phase 1 TH-302 Mass Balance Trial

Summary

This is an open-label, Phase 1, two-center trial to evaluate the mass balance and metabolite profile of carbon 14 \[14C\]-labeled TH-302 (Label 1 and Label 2) followed by subsequent treatment with unlabeled TH-302 in cancer subjects with locally advanced or metastatic solid tumors.

Timeline

Start

2014-02

Primary completion

2014-09

Completion

2016-03

Drugs

Indications